Target Price | $190.74 |
Price | $177.83 |
Potential |
7.26%
register free of charge
|
Number of Estimates | 19 |
19 Analysts have issued a price target Quest Diagnostics 2026 .
The average Quest Diagnostics target price is $190.74.
This is
7.26%
register free of charge
$210.00
18.09%
register free of charge
$160.28
9.87%
register free of charge
|
|
A rating was issued by 24 analysts: 13 Analysts recommend Quest Diagnostics to buy, 11 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Quest Diagnostics stock has an average upside potential 2026 of
7.26%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 9.87 | 10.90 |
6.70% | 10.38% | |
EBITDA Margin | 15.55% | 19.88% |
1.03% | 27.85% | |
Net Margin | 8.77% | 10.07% |
4.52% | 14.79% |
21 Analysts have issued a sales forecast Quest Diagnostics 2025 . The average Quest Diagnostics sales estimate is
This results in the following potential growth metrics:
18 Analysts have issued an Quest Diagnostics EBITDA forecast 2025. The average Quest Diagnostics EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
22 Quest Diagnostics Analysts have issued a net profit forecast 2025. The average Quest Diagnostics net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 7.66 | 9.79 |
1.86% | 27.81% | |
P/E | 18.16 | |
EV/Sales | 2.34 |
22 Analysts have issued a Quest Diagnostics forecast for earnings per share. The average Quest Diagnostics EPS is
This results in the following potential growth metrics and future valuations:
Quest Diagnostics...
Analyst | Rating | Action | Date |
---|---|---|---|
JP Morgan |
Locked
➜
Locked
|
Locked | May 06 2025 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Apr 28 2025 |
Evercore ISI Group |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
Truist Securities |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
Baird |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Apr 23 2025 |
Mizuho |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
Analyst Rating | Date |
---|---|
Locked
JP Morgan:
Locked
➜
Locked
|
May 06 2025 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Apr 28 2025 |
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Apr 23 2025 |
Locked
Truist Securities:
Locked
➜
Locked
|
Apr 23 2025 |
Locked
Baird:
Locked
➜
Locked
|
Apr 23 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Apr 23 2025 |
Locked
Mizuho:
Locked
➜
Locked
|
Apr 09 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.